Vanda Pharmaceuticals Inc

Company Profile

Vanda Pharmaceuticals Inc had its IPO on 2006-04-12 under the ticker symbol VNDA.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Vanda Pharmaceuticals Inc has a staff strength of 0 employees.

Stock update

Shares of Vanda Pharmaceuticals Inc opened at $10.56 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $10.3 - $10.65, and closed at $10.31.

This is a -3.1% slip from the previous day's closing price.

A total volume of 391,962 shares were traded at the close of the day’s session.

In the last one week, shares of Vanda Pharmaceuticals Inc have increased by +3.1%.

Vanda Pharmaceuticals Inc's Key Ratios

Vanda Pharmaceuticals Inc has a market cap of $0.583 billion, indicating a price to book ratio of 1.18 and a price to sales ratio of 2.22.

In the last 12-months Vanda Pharmaceuticals Inc’s revenue was $0.263 billion with a gross profit of $0.243 billion and an EBITDA of $0.018 billion. The EBITDA ratio measures Vanda Pharmaceuticals Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Vanda Pharmaceuticals Inc’s operating margin was 5.8% while its return on assets stood at 1.62% with a return of equity of 2.22%.

In Q2, Vanda Pharmaceuticals Inc’s quarterly earnings growth was a negative -73.2% while revenue growth was a negative 5.2%.

Vanda Pharmaceuticals Inc’s PE and PEG Ratio

Forward PE

30.3

Trailing PE

54.26

PEG

-2.42

Its diluted EPS in the last 12-months stands at $0.19 per share while it has a forward price to earnings multiple of 30.3 and a PEG multiple of -2.42. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vanda Pharmaceuticals Inc’s profitability.

Vanda Pharmaceuticals Inc stock is trading at a EV to sales ratio of 0.65 and a EV to EBITDA ratio of 9.46. Its price to sales ratio in the trailing 12-months stood at 2.22.

Vanda Pharmaceuticals Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$0.000 billion

Total Liabilities

$0.000 billion

Operating Cash Flow

$0.000 billion

Capital Expenditure

$0.000 billion

Dividend Payout Ratio

0%

Vanda Pharmaceuticals Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Vanda Pharmaceuticals Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Vanda Pharmaceuticals Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Vanda Pharmaceuticals Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Vanda Pharmaceuticals Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price

$10.31

52-Week High

$18.55

52-Week Low

$9.24

Analyst Target Price

$11

Vanda Pharmaceuticals Inc stock is currently trading at $10.31 per share. It touched a 52-week high of $18.55 and a 52-week low of $18.55. Analysts tracking the stock have a 12-month average target price of $11.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.